aid: iliad-biotechnologies
name: ILiAD Biotechnologies
description: 'ILiAD Biotechnologies, Inc. is a privately held, clinical-stage biotechnology
  company headquartered in Weston, Florida, developing BPZE1 — a live attenuated intranasal
  vaccine candidate designed to prevent Bordetella pertussis (whooping cough) colonization
  and transmission — alongside its B-Tech vector platform, which the company is exploring
  for infectious, allergic, autoimmune and neurodegenerative disease. The BPZE1 technology
  originated at Institut Pasteur de Lille and is exclusively licensed to ILiAD, which
  announced a $115M Series B in February 2026 and received a UK MHRA Innovation Passport
  designation in December 2024. ILiAD publishes a static corporate and scientific website
  only: as of 2026-08-22 it operates no public API, developer portal, SDK, machine-readable
  specification, or any other programmable surface.'
image: https://iliadbio.com/images/logo1.png
url: https://raw.githubusercontent.com/api-evangelist/iliad-biotechnologies/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-08-22'
modified: '2026-08-22'
tags:
- Company
- Biotechnology
- Vaccines
- Life Sciences
- Pharmaceuticals
- Health
- Immunology
- Infectious Disease
- Clinical Trials
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://iliadbio.com/
- type: About
  url: https://iliadbio.com/company/overview.html
- type: News
  url: https://iliadbio.com/company/news.html
- type: Investors
  url: https://iliadbio.com/company/for-investors.html
- type: Careers
  url: https://iliadbio.com/careers.html
- type: ContactUs
  url: https://iliadbio.com/contact-us.html
- type: PrivacyPolicy
  url: https://iliadbio.com/privacy-policy.html
- type: DomainSecurity
  url: security/iliad-biotechnologies-domain-security.yml
- type: LLMsTxt
  url: llms/iliad-biotechnologies-llms.txt
- type: Team
  url: https://iliadbio.com/team/executive-board.html
- type: Product
  name: BPZE1 intranasal pertussis vaccine
  url: https://iliadbio.com/our_science/bpze1_vaccine.html
- type: Pipeline
  url: https://iliadbio.com/opportunity/pipeline.html
- type: Publications
  url: https://iliadbio.com/our_science/publications.html
x-enrichment:
  date: '2026-08-22'
  status: minimal
  artifacts_added: 3
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: >-
    ILiAD Biotechnologies is a clinical-stage vaccine developer whose product is BPZE1, a live
    attenuated intranasal pertussis vaccine in human trials — not software — and iliadbio.com is
    an 88-page static HTML site of science, patent PDFs and press releases where /openapi.json,
    /graphql, /api-docs, /llms.txt and every /.well-known/ path return a real 404, and
    api./docs./developer.iliadbio.com do not resolve in DNS.
  evidence:
  - url: https://iliadbio.com/openapi.json
    status: 404
  - url: https://iliadbio.com/graphql
    status: 404
  - url: https://iliadbio.com/.well-known/agent-card.json
    status: 404
  - url: https://iliadbio.com/llms.txt
    status: 404
  - url: https://iliadbiotech.com/.well-known/security.txt
    status: 404
  checked: '2026-08-22'